Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.245 USD | -0.40% | -1.97% | -17.00% |
May. 08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 112M |
---|---|---|---|---|---|
Net income 2024 * | -99M | Net income 2025 * | -100M | EV / Sales 2024 * | - |
Net cash position 2024 * | 33.12M | Net Debt 2025 * | 55.55M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.24
x | P/E ratio 2025 * |
-1.42
x | Employees | 80 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.28% |
Latest transcript on Immunic, Inc.
1 day | -0.40% | ||
1 week | -1.97% | ||
Current month | -1.19% | ||
1 month | +2.89% | ||
3 months | -1.19% | ||
6 months | +17.45% | ||
Current year | -17.00% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Vitt
CEO | Chief Executive Officer | 55 | 16-12-31 |
Glenn Whaley
DFI | Director of Finance/CFO | 56 | 19-11-30 |
Hella Kohlhof
CTO | Chief Tech/Sci/R&D Officer | 51 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barclay Phillips
BRD | Director/Board Member | 61 | 19-11-18 |
Tamar Howson
BRD | Director/Board Member | 75 | 19-10-10 |
Jörg Neermann
BRD | Director/Board Member | 57 | 19-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.245 | -0.40% | 1,411,370 |
24-05-16 | 1.25 | -3.47% | 244,759 |
24-05-15 | 1.295 | +1.17% | 137,150 |
24-05-14 | 1.28 | +1.99% | 162,825 |
24-05-13 | 1.255 | -1.18% | 120,657 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.00% | 112M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- IMUX Stock